Clinical Research and Regulatory Affairs,volume 30,issue 4  (12-2013)

Period of time： 2013年4期

Publisher： Informa Healthcare

Founded in： 1983

Total resources： 4

ISSN： 1060-1333

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Research and Regulatory Affairs,volume 30,issue 4

Menu

Reducing the average number of patients needed in a phase II trial through novel design

By Wason James M. S. in (2013)

Clinical Research and Regulatory Affairs,volume 30,issue 4 , Vol. 30, Iss. 4, 2013-12 , pp. 47-54

Informa Healthcare

Abstract Access to resources Recommend Favorite

The pharmacodynamic equivalence of Orlistat 60 mg capsule. An open label, balanced, randomized, multiple-dose, cross-over pharmacodynamic end-point bioequivalence study in healthy, adult, human Asian Indian subjects under fed conditions

By Kumar Sudershan,Monif Tausif,Arora Rachna,Khuroo Arshad,Jain Rakesh,Reyar Simrit,Verma Priya Ranjan Prasad,Rao Shireen in (2013)

Clinical Research and Regulatory Affairs,volume 30,issue 4 , Vol. 30, Iss. 4, 2013-12 , pp. 55-62

Informa Healthcare

Abstract Access to resources Recommend Favorite

Total 2 item(s)